Singular Genomics Systems Inc
OMIC
Get informed when a big investor buys or sells
+ FollowMarket Cap$50.77M
Close$
$-0.90
104.5% downside
Current Fair Value
104.5% downsideOvervalued by 104.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $50.77 Million |
|---|---|
| Enterprise Value | $48.64 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-39.08 |
| Beta | 1.84 |
| Outstanding Shares | 2,501,093 |
Return
| Return on Equity | -70.04% |
|---|---|
| Return on Assets | -46.27% |
| Return on Invested Capital | -54.73% |
Valuation & Multiples
| P/E Ratio | -0.51 |
|---|---|
| PEG | 2.06 |
| Price to Sales | 20.01 |
| Price to Book Ratio | 0.41 |
| Enterprise Value to Revenue | 18.24 |
| Enterprise Value to EBIT | -0.53 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.04 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 10, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Singular Genomics Systems Inc
138 employees